Takeda agrees to develop active immunotherapy for Alzheimer’s
As part of the agreement, AC Immune SA will be…
As part of the agreement, AC Immune SA will be eligible for an option exercise fee and extra potential milestones of up to approximately $2.1 billion from Takeda.